Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Fig 5
A. Counts of unique SARS-CoV-2 mutations for each epidemic week, with colours representing which continent the mutations came from. B. Counts of unique mutations per week that are part of the mutational signature substitution-context features (i.e., no indel mutations included). Colours represent which lineage/group of lineages the mutations belong to. C. Ridgeline plot showing the exposure of mutational signatures in SARS-CoV-2 variant-defined subsets. Exposures are coloured by the signature they have been attributed to. D. Ridgeline plot showing the exposure of mutational signatures in SARS-CoV-2 continent-defined subsets.